Электронный научный журнал

The problem of diagnosis, clinic and treatment of dyscirculatory encephalopathy is urgent. In dyscirculatory encephalopathy, the main directions of therapeutic measures are general therapeutic effects and measures to prevent the development and progression of vascular dementia. Currently, a search is underway for new effective safe drugs for the treatment of patients with dyscirculatory encephalopathy. For the treatment of neurological manifestations in these patients, the use of peptide drugs is considered. To study the effect of peptide drugs (cytamines) on clinical and neurological changes in patients with dyscirculatory encephalopathy, this study was conducted, during which it was shown that the use of cytamines leads to an improvement in clinical and neurological disorders of various origins.